Cargando…
Cholesterol 25‐Hydroxylase inhibits SARS‐CoV‐2 and other coronaviruses by depleting membrane cholesterol
Coronavirus disease 2019 (COVID‐19) is caused by SARS‐CoV‐2 and has spread across the globe. SARS‐CoV‐2 is a highly infectious virus with no vaccine or antiviral therapy available to control the pandemic; therefore, it is crucial to understand the mechanisms of viral pathogenesis and the host immune...
Autores principales: | Wang, Shaobo, Li, Wanyu, Hui, Hui, Tiwari, Shashi Kant, Zhang, Qiong, Croker, Ben A, Rawlings, Stephen, Smith, Davey, Carlin, Aaron F, Rana, Tariq M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537045/ https://www.ncbi.nlm.nih.gov/pubmed/32944968 http://dx.doi.org/10.15252/embj.2020106057 |
Ejemplares similares
-
Cholesterol 25-hydroxylase suppresses porcine deltacoronavirus infection by inhibiting viral entry
por: Ke, Wenting, et al.
Publicado: (2021) -
Cholesterol 25-hydroxylase negatively regulates porcine intestinal coronavirus replication by the production of 25-hydroxycholesterol
por: Zhang, Yunhang, et al.
Publicado: (2019) -
Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids
por: Tiwari, Shashi Kant, et al.
Publicado: (2021) -
Genomics and proteomics of vertebrate cholesterol ester lipase (LIPA) and cholesterol 25-hydroxylase (CH25H)
por: Holmes, Roger S., et al.
Publicado: (2011) -
Research progress on the mechanism of cholesterol-25-hydroxylase in intestinal immunity
por: Zhong, Guoqiang, et al.
Publicado: (2023)